MC2 Biotek is a biotechnology company established in 2006,[1] with offices in Denmark and external labs in the United Kingdom.

Zadec focuses on Diabetes and nutrition, and has developed an oral anti-diabetes drug, RX-1, which is currently in clinical trials.

[7] A 2008 PAD patent claims that this foam-like emulsion is stable with up to at least 70% dispersed oil phase and at most 3% surfactant.

[7] Manufacturing using this technology is simple and low cost compared to gastroretentive dosage forms (GRDF) in the prior art.

[citation needed] MC2 Biotek has also developed a 3D ProtoTissue™ Bioreactor, which allows cells from an immortal human hepatocyte line to grow into 3D spheroids.